Microencapsulation of pancreatic islets represents a potentially effective method to prevent graft rejection in allotransplantation or xenotransplantation without the need of immunosuppression. Adequate insulin secretion and glucose responsiveness of microencapsulated pancreatic islets has been regarded as a prerequisite for successful transplantation. The microencapsulated pancreatic islets were respectively cultured in bFGF+ RPMI-1640 medium (bFGF+) or bFGF− RPMI-1640 medium (bFGF−) for 21 days. The functional activities of microencapsulated pancreatic islets were assessed by measuring basal insulin secretion and stimulated insulin release at different time points. The results revealed that microencapsulated pancreatic islets in the presence of bFGF demonstrated an increase in basal insulin secretion. Furthermore, microencapsulated pancreatic islets in the presence of bFGF demonstrated a marked stimulated insulin release and relative stability of stimulation indices (SI). The results in the perifusion study showed that microencapsulated pancreatic islets in the presence of bFGF maintained good glucose responsiveness over the course of culture period as well. These results indicate that bFGF has a beneficial effect on insulin secretion from microencapsulated pancreatic islets during in vitro culture. New strategies for preserving and improving function of microencapsulated pancreatic islets prior to transplantation may be developed by application of growth factors or other factors.
INTRODUCTION
Besides immune rejection, inadequate microvascularization of the grafts has been suggested to be a culprit Transplantation of pancreatic islets represents an atin achieving successful islet transplant (16, 20, 27) . Retractive approach for curative treatment of insulincently, it has become apparent that the development of dependent diabetes mellitus (IDDM). However, a numdysfunction and early death of islets has been also docuber of obstacles currently prevent islet transplantation mented. This high rate of nonfunction and early dysfrom becoming routine clinical reality. A significant obfunction has been attributed to poorly viable or poorly stacle is the continued problem of immunologic rejecfunctional islets presumably damaged during isolation tion of the grafted islets (1,3). A number of strategies (4, 8) . It is probable that the destruction of the islet mihave arisen to circumvent the problem of immune rejeccroenvironment and the loss of capillary bed and trophic tion. Microencapsulation of pancreatic islets has been support that occur during isolation, purification, and in regarded as a potentially effective method to prevent the pretransplant culture period subject the islets to a graft rejection in allotransplantation or xenotransplantacellular stress that could impair β-cell function and surtion without the need of immunosuppression. In our labvival (2,24). It has been suggested that islet hormone oratory, a novel type of agarose microcapsule has resecretion and islet regulatory system depend upon the cently been developed for greater effectiveness in intraislet microvasculature. Recently, some efforts have xenogenic islet transplantation (11, 25) . However, a critibeen undertaken to maintain and improve islet function cal evaluation of the literature reveals that success has and survival following islet isolation by preserving miso far been very limited (21). crovasculature of pancreatic islets and reestablishing is-466 WANG ET AL. let-matrix relationship. It has been shown that it is pos-islets and cultured in RPMI-1640 medium supplemented sible to preserve the native islet microvascular system with 10% FBS, antibiotics, 20 ng/ml bFGF, and 90 µg/ by treatment with angiogenic growth factors (23). ml heparin (bFGF+, n = 6) for 21 days. Microencapsu-Adequate insulin secretion and glucose responsivelated pancreatic islets cultured in RPMI-1640 medium ness of microencapsulated pancreatic islets has been rein the absence of bFGF served as a control (bFGF−, n = garded as a prerequisite for successful transplantation. It 6). The respective media were changed every other day, needs to be determined whether an appropriate function and insulin release into culture medium was taken for of microencapsulated pancreatic islets prior to transplanmeasuring basal insulin secretion. tation can be preserved by treatment with bFGF. The
To study glucose responsiveness, microencapsulated current study was conducted to evaluate the effect of pancreatic islets cultured in bFGF+ and bFGF− RPMI-bFGF on insulin secretion from microencapsulated pan-1640 medium were respectively processed for static increatic islets in vitro.
cubation on days 1, 7, 14, and 21 and for perifusion study on days 1 and 21.
MATERIALS AND METHODS
In the static incubation, microencapsulated pancreatic Islet Isolation islets handpicked from each group were respectively Islets were isolated from male Syrian golden hamseeded in 24-well plates, each well seeded with 20 misters by a modification of the collagenase technique for croencapsulated pancreatic islets (n = 6) and washed rat islet isolation (12, 13) . The pancreas was resected, with Krebs-Ringer bicarbonate buffer (KRBB) containchopped, and incubated with collagenase S-1 from ing 3.3 mM glucose and 0.2% BSA. After 30-min prein-Streptomyces parvulus subsp. citrinus (Nitta Gelatin, cubation in 2 ml KRBB containing 3.3 mM glucose and Osaka, Japan). Isolated islets were handpicked under a 0.2% BSA at 37°C, the microencapsulated pancreatic isdissecting microscope with the aid of a Pasteur-pipette lets were incubated in 2 ml KRBB containing 16.7 mM and cultured for 24 h in an atmosphere of 5% CO 2 and glucose and 0.2% BSA for 30 min. Finally, the microen-95% air at 37°C in uncoated plastic petri dishes before capsulated pancreatic islets were washed with KRBB microencapsulation. The tissue culture medium was containing 3.3 mM glucose and 0.2% BSA and then in-RPMI-1640 supplemented with 10% heat-inactivated fecubated in 2 ml KRBB containing 3.3 mM glucose and tal bovine serum (FBS), 100 mg/dl D-glucose, and anti-0.2% BSA for an additional 30 min. Samples for insulin biotics.
analysis were collected at the end of each incubation period.
Microencapsulation
In the perifusion study, microencapsulated pancreatic Isolated islets were microencapsulated using a mixislets cultured in bFGF+ and bFGF− RPMI-1640 meture of 5% agarose and 5% polystyrene sulfonic acid dium were respectively subjected to perifusion study on (PSSa) according to Iwata's method (10) . days 1 and 21. Twenty microencapsulated pancreatic islets handpicked from each group were placed in a plastic Culture, Static Incubation, and Perifusion Study flow-through perifusion chamber (Millipore Corp.). The After overnight recovery in RPMI-1640 medium supmicroencapsulated pancreatic islets were perifused for plemented with 10% FBS and antibiotics, two experi-50 min at 37°C, at the flow rate of 0.5 ml/min, with mental groups were established: bFGF− group: microen-KRBB, containing 1% BSA and a basal 3.3 mM (60 capsulated pancreatic islets placed in suspension culture mg/dl) glucose, maintained at pH 7.4 by continuous gasin RPMI-1640 medium supplemented with 10% FBS sing with 95% O 2 /5% CO 2 in an unsealed reservoir. The and antibiotics; bFGF+ group: microencapsulated panperifusion experiments on days 1 and 21 were conducted creatic islets maintained as bFGF− group, but supplewith double chambers and triplicate chambers, respecmented with 20 ng/ml bFGF and 90 µg/ml heparin. Mitively. croencapsulated pancreatic islets were cultured in an After the 50-min preperifusion, basal effluent samatmosphere of 5% CO 2 and 95% air at 37°C for all of ples were periodically collected at 2-min intervals on ice the experimental procedure and the medium was with a fraction collector for 10 min before the microenchanged on alternate days. The functional activities of capsulated pancreatic islets were then perifused with the microencapsulated pancreatic islets were assessed by KRBB solution containing 16.7 mM (300 mg/dl) for 60 measuring basal insulin secretion and stimulated insulin min, during which samples were again collected at interrelease. Insulin concentrations were measured with an vals. Following the 16.7 mM glucose stimulation, a enzyme immunoassay kit (Glazyme, Sanyo, Japan).
washout perifusion with the 3.3 mM glucose buffer was Microencapsulated pancreatic islets handpicked from performed for 30 min with sample collection. Solutions each group were respectively seeded in 24-well plates, each well seeded with 20 microencapsulated pancreatic were changed using a stopcock and all effluent perifu-EFFECT OF bFGF ON INSULIN SECRETION 467 sate samples obtained throughout the study were stored on days 14 and 21 exhibited a clear-cut decrease in stimulated insulin release, which was 4.61 ± 0.84 and 5.91 ± frozen at −20°C for subsequent insulin assay. 0.90 µU/islet/30 min, respectively. In comparison, mi-Data Analysis croencapsulated pancreatic islets cultured in bFGF+ Basal insulin secretion and stimulated insulin release RPMI-1640 medium on days 14 and 21 demonstrated a were expressed as mean and SD of each group. Insulin marked stimulated insulin release, which was 11.73 ± SI was calculated according to the ratio of stimulated 1.44 and 9.25 ± 1.27 µU/islet/30 min, respectively, sig-(16.7 mM glucose) to basal (3.3 mM glucose) insulin nificantly higher than that in bFGF− RPMI-1640 merelease (14) . Comparisons between each parameter were dium at the same time point studied (Fig. 2) . Furtherperformed by Student's t-test. Statistical significance more, microencapsulated pancreatic islets cultured in was considered to be p < 0.05. bFGF− RPMI-1640 medium on days 7, 14, and 21 showed a gradual decline tendency of insulin SI, which RESULTS was 3.15 ± 0.77, 2.12 ± 0.48, and 1.85 ± 0.41, respec-Microencapsulated pancreatic islets cultured in tively. In comparison, microencapsulated pancreatic is-bFGF+ and bFGF− RPMI-1640 medium revealed all lets cultured in bFGF+ RPMI-1640 medium demonfluctuant curves in basal insulin secretion during the inistrated relative stability of insulin SI, which was 3.84 ± tial 9 days of culture. There were no significant differ-0.77, 3.93 ± 1.00, and 3.07 ± 0.63, respectively. There ences in basal insulin secretion between the bFGF+ were significant differences at the same time point studgroup and the bFGF− group during the initial 9 days of ied between the bFGF+ and bFGF− groups (Fig. 3 ). culture. From day 9, microencapsulated pancreatic islets
In the perifusion study, microencapsulated pancreatic cultured in bFGF− RPMI-1640 medium showed a relaislets cultured in bFGF+ RPMI-1640 medium on day 1 tive decline tendency in basal insulin secretion. In comshowed a dose-related biphasic insulin secretion with parison, microencapsulated pancreatic islets cultured in brisk first phase insulin release, which was consistent bFGF+ RPMI-1640 medium demonstrated an increase with that in bFGF− RPMI-1640 medium (Fig. 4A ). Miin basal insulin secretion from day 9 to day 21, which croencapsulated pancreatic islets cultured in bFGF+ was significantly higher than that in bFGF− RPMI-1640 RPMI-1640 medium on day 21 maintained a markedly medium at the same time point studied (Fig. 1) .
favorable dose-related biphasic insulin secretion with In the static incubation, stimulated insulin release in brisk first phase insulin release similar to that on day 1, response to glucose stimulation (16.7 mM glucose) had whereas microencapsulated pancreatic islets cultured in no significant difference between the bFGF+ group and bFGF− RPMI-1640 medium on day 21 did not displayed the bFGF− group on days 1 and 7. Microencapsulated a dose-related biphasic insulin secretion with brisk first phase insulin release (Fig. 4B ). pancreatic islets cultured in bFGF− RPMI-1640 medium 
DISCUSSION
as survival (23). A neovascularization-inducing bioartificial pancreas by application of polyethylene tereph-The present study shows that microencapsulated panthalate mesh and bFGF has been developed in our labocreatic islets maintain adequate function during in vitro ratory and employed for syngeneic islet graft (6,7). culture in the presence of bFGF.
Fibroblast growth factors (FGF) are members of a pro-The use of growth factors in the induction of targeted tein family that induce mitogenic, chemotactic, and anangiogenesis may have relevance in many areas of biolgiogenic activity in a variety of cells of epithelial, mesogy and medicine, including the transplantation of tisenchymal, and neural origins. As a consequence of their sues such as the pancreatic islet, which are dependent upon the microvasculature for normal function as well strong affinity for heparin, FGFs are also referred to as heparin-binding growth factors (HBGFs) (29). Acidic fi-tissues and especially by tissues with high angiogenic activity. It belongs to a well-characterized family of en-broblast growth factor (aFGF) and bFGF, two original members of the FGF family, have similar but distin-dothelial cell mitogens (18, 19) . The responses of endothelial cells to bFGF in vitro include changes in cell guishable biological activities and exhibit approximately 55% sequence identity. bFGF is an 18,000-Da protein morphology, stimulation of cell proliferation and migration, and increased synthesis and release of lytic en-produced by various mesodermal and neuroectodermal zymes such as plasminogen activator and collagenase.
insulin release reflects a complex integration of intracellular and extracellular influence (28). The microvascula-In vivo, bFGF was shown to induce neoangiogenesis and to promote wound healing (19) .
ture of pancreatic islets may be critical for normal intercellular communication and, consequently, for insulin Concerned with the effects of angiogenic growth factors on islets, it has been reported that ECGF and aFGF release regulation. Our data exhibited further that microencapsulated pancreatic islets in the presence of bFGF enhance the revascularization process in transplanted islets. It appears from other observations that aFGF-demonstrated a marked stimulated insulin release and relative stability of insulin SI. The results in the peri-induced revascularization may also partially "normalize" the revascularization of transplanted islets as suggested fusion study showed also that microencapsulated pancreatic islets in the presence of bFGF maintained a by the histology of the islets and the increase in insulin and the decrease in glucagon secretion from the same favorable performance of dose-related biphasic insulin secretion with brisk first phase insulin release. It is clear number of islets transplanted in the presence of aFGF. Our data clearly revealed that microencapsulated pancre-that good glucose responsiveness was preserved in the presence of bFGF. These results indicated that the bene-atic islets in the presence of bFGF demonstrated an increase in basal insulin secretion. The current interpre-ficial effect of bFGF on insulin secretion from microencapsulated pancreatic islets demonstrated in the present tation of increase in insulin secretion from microencapsulated pancreatic islets in the presence of bFGF re-study may be attributed to preservation of native islet microvascular system by application of bFGF in the mains enigmatic. It is speculated that effect of bFGF on function of pancreatic islets may be related to microvas-curse of culture in vitro. The detailed mechanism certainly needs to be further clarified by another approach. culature of pancreatic islets.
The microvasculature of pancreatic islets is an often In conclusion, the study reported here indicates that bFGF has beneficial effect on insulin secretion from mi-overlooked but important structure in islet function and regulation. The microvasculature of pancreatic islets in croencapsulated pancreatic islets during in vitro culture.
Our study also suggests that new strategies for preserv-situ is characterized by a glomerulum-like network of capillaries presenting with an intraislet portal system, ing and improving function of microencapsulated pancreatic islets prior to transplantation may be developed which determines the order of microvascular perfusion.
by application of growth factors or other factors. It has been proposed to play the pivotal role in intraislet cellular communication, in particular according to the
